APA (7th ed.) Citation

Lee, C. L., Freeman, M., Burak, K. W., Moffat, G. T., O'Donnell, C. D. J., Ding, P. Q., . . . Tam, V. C. (2024). Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications. Cancers, 16(16), 2878. https://doi.org/10.3390/cancers16162878

Chicago Style (17th ed.) Citation

Lee, Cha Len, et al. "Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications." Cancers 16, no. 16 (2024): 2878. https://doi.org/10.3390/cancers16162878.

MLA (9th ed.) Citation

Lee, Cha Len, et al. "Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications." Cancers, vol. 16, no. 16, 2024, p. 2878, https://doi.org/10.3390/cancers16162878.